Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: A case report

dc.authoridErdogan, Esin/0000-0003-0100-652X
dc.authorwosidErdogan, Esin/AAK-4303-2020
dc.contributor.authorTuglu, C
dc.contributor.authorErdogan, E
dc.contributor.authorAbay, E
dc.date.accessioned2024-06-12T11:07:44Z
dc.date.available2024-06-12T11:07:44Z
dc.date.issued2005
dc.departmentTrakya Üniversitesien_US
dc.description.abstractWe report an elderly patient who developed severe delirium and extrapyramidal signs after initiation of lithium-olanzapine combination. On hospital admission, serum levels of lithium were found to be 3.0 mM/L which were far above toxic level. Immediate discontinuation of both drugs resulted in complete resolution of most of the symptoms except for perioral dyskinesia which persisted for three more months. We critically discussed the differential diagnosis of lithium intoxication and assessed confounding factors which induce delirium and extrapyramidal signs related with combination therapy of lithium and olanzapine.en_US
dc.identifier.doi10.3346/jkms.2005.20.4.691
dc.identifier.endpage694en_US
dc.identifier.issn1011-8934
dc.identifier.issue4en_US
dc.identifier.pmid16100469en_US
dc.identifier.scopus2-s2.0-24644437493en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage691en_US
dc.identifier.urihttps://doi.org/10.3346/jkms.2005.20.4.691
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22171
dc.identifier.volume20en_US
dc.identifier.wosWOS:000231633500031en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKorean Acad Medical Sciencesen_US
dc.relation.ispartofJournal Of Korean Medical Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLithiumen_US
dc.subjectDrug Toxicityen_US
dc.subjectAntipsychotic Agentsen_US
dc.subjectOlanzapineen_US
dc.subjectDeliriumen_US
dc.subjectNeurologic Manifestationsen_US
dc.subjectNeurolepticen_US
dc.subjectNeuroleptic Malignant Syndromeen_US
dc.subjectAtypical Antipsychoticsen_US
dc.subjectNeurotoxicityen_US
dc.subjectKetoacidosisen_US
dc.subjectParkinsonismen_US
dc.subjectIntoxicationen_US
dc.subjectSequelaeen_US
dc.subjectPatienten_US
dc.titleDelirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: A case reporten_US
dc.typeArticleen_US

Dosyalar